AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Ethinylestradiol A
9 registrations across 1 African market— 7 active
Markets with Ethinylestradiol A
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| MINESSE | 🇿🇦South Africa | Pfizer Laboratories (Pty) Ltd | suspended | Apr 2024 |
| TRIODENE ED | 🇿🇦South Africa | Bayer (Pty) Ltd û Isando | suspended | Oct 2022 |
| MIRELLE | 🇿🇦South Africa | Bayer (Pty) Ltd û Isando | active | Jan 1900 |
| FAMYNOR | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Jan 1900 |
| LOETTE 28 | 🇿🇦South Africa | Pfizer Laboratories (Pty) Ltd | active | Jan 1900 |
| BIPHASIL | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| LOGYNON ED | 🇿🇦South Africa | Bayer (Pty) Ltd û Isando | active | Jan 1900 |
| ORALCON | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Jan 1900 |
| TRIGESTREL | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Jan 1900 |
Ethinylestradiol A in Africa — Regulatory Overview
Ethinylestradiol A is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 7 (78%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.